Related Experiment Video
Updated: Jun 10, 2025
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Biologics in Asthma: Potential to Achieve Clinical Remission
Orlando Rivera1, Rohit Katial1, Flavia C L Hoyte1
1Division of Allergy and Immunology, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
A universal definition for asthma remission is needed to improve patient outcomes and guide research. This study examines proposed definitions and the role of biologics in achieving remission.
Area of Science:
- Pulmonology and Respiratory Medicine
- Clinical Therapeutics
Background:
- Asthma remission lacks a consensus definition, hindering standardized treatment and research.
- Multidisciplinary efforts have yet to establish a universal definition for asthma remission.
Purpose of the Study:
- To explore the evolving concept of asthma remission.
- To discuss proposed definitions and the role of biologics in achieving asthma remission.
- To emphasize the need for a consensus definition to standardize treatment goals.
Main Methods:
- Literature review of proposed asthma remission definitions.
- Analysis of international guidelines on asthma management.
- Evaluation of studies on biologic therapies for asthma remission.
Main Results:
- Various definitions of asthma remission exist, but none have achieved consensus.
- Biologic therapies show potential in achieving clinical remission in asthma patients.
- Current guidelines do not uniformly address asthma remission criteria.
Conclusions:
- A consensus definition for asthma remission is crucial for advancing research and improving patient care.
- Biologics represent a promising therapeutic avenue for achieving asthma remission.
- Standardizing treatment goals through a universal definition will enhance asthma management.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.